A pancreatic cancer vaccine in its first phase of trial has shown encouraging outcomes. The results were published on Wednesday in Nature, a scientific journal. Out of 16 trial participants
Tag "messenger RNA (mRNA) vaccine"
Advertisement
Advertisement
Advertisement
Advertisement
Top Stories
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Life and Living
Advertisement
Advertisement